Public Institutional Investor Capital Eyes Access to Clinical Trial Company

The upward sloping trend of mega pharmaceuticals outsourcing research, development and operations continues to thrive. Wilmington, North Carolina-based Pharmaceutical Product Development LLC, a clinical research company, could have some new foreign institutional owners. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates